Sanofi, founded in 2004 and headquartered in Paris, France, is a global healthcare leader dedicated to improving health and well-being through innovative pharmaceuticals and vaccines. The company’s portfolio focuses on key therapeutic areas, including diabetes, oncology, immunology, and rare diseases, alongside a strong commitment to research and development.
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Sanofi has actively participated in the bond market since 2007, issuing multiple bonds to finance its growth and acquisitions. A notable issuance was the €2 billion bond in 2020, which helped fund the acquisition of principled biotech firms, enhancing its pipeline. Currently, Sanofi's bond yields remain competitive within the pharmaceutical industry, attracting fixed-income investors seeking stability amid market volatility. The company has also issued green bonds to promote sustainable practices, reflecting its commitment to environmental responsibility in investment.